Data-driven structural analysis of small cell lung cancer transcription factor network suggests potential subtype

Mustafa Ozen1,2, Carlos F Lopez3,4

  • 1Dept. of Biochemistry, Vanderbilt University, Nashville, TN, USA.

PubMed

Insights

This study reveals that key regulatory hubs in small cell lung cancer (SCLC) networks control subtype transitions. Analyzing network structure identifies critical components like MYC, offering new therapeutic targets for this aggressive cancer.

Area of Science:

  • Computational Biology
  • Systems Biology
  • Oncology

Background:

  • Small cell lung cancer (SCLC) is aggressive and difficult to treat due to transcriptional heterogeneity and subtype plasticity.
  • Transcription factor (TF) networks are implicated in SCLC regulation, but their structural properties and role in subtype dynamics remain understudied.
  • Understanding TF network architecture is crucial for identifying drivers of SCLC subtypes and transitions.

Purpose of the Study:

  • To analyze the structural organization of the SCLC TF network using graph theory.
  • To identify structurally important components (hubs) within the SCLC TF network.
  • To investigate the role of network hubs and pathways in regulating SCLC subtype transitions.

Main Methods:

  • Applied graph theory concepts to analyze the structure of the SCLC TF network.
  • Integrated RNA-sequencing data to weight interactions within the network.
  • Performed network simulations to test hypotheses regarding pathways controlling subtype transitions.

Main Results:

  • Identified network hubs that act as regulators of different SCLC subtypes.
  • Data-driven analysis highlighted MYC as a significant hub, aligning with existing research.
  • Network simulations demonstrated that pathways connecting distinct hubs can induce subtype transitions.

Conclusions:

  • Structural analysis of complex biological networks can reveal functionally critical components and pathways.
  • Identifying network hubs and pathways provides a basis for generating hypotheses in SCLC research.
  • This approach can guide the discovery of novel therapeutic targets to alter SCLC network dynamics and phenotypes.

Related Concept Videos

Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
Combinatorial Gene Control02:33

Combinatorial Gene Control

Combinatorial gene control is the synergistic action of several transcriptional factors to regulate the expression of a single gene. The absence of one or more of these factors may lead to a significant difference in the level of gene expression or repression.
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
8.4K
General Transcription Factors01:30

General Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
5.3K
Transcription Factors02:16

Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
76.0K
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
7.4K